| Oxidized phospholipids on lipoprotein (a) elicit arterial wall inflammation and an inflammatory monocyte response in humans FM van der Valk, S Bekkering, J Kroon, C Yeang, J Van den Bossche, ... Circulation 134 (8), 611-624, 2016 | 568 | 2016 |
| Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice X Que, MY Hung, C Yeang, A Gonen, TA Prohaska, X Sun, C Diehl, ... Nature 558 (7709), 301-306, 2018 | 497 | 2018 |
| Lipoprotein (a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association G Reyes-Soffer, HN Ginsberg, L Berglund, PB Duell, SP Heffron, ... Arteriosclerosis, Thrombosis, and vascular biology 42 (1), e48-e60, 2022 | 461 | 2022 |
| Statin therapy increases lipoprotein (a) levels S Tsimikas, PLSM Gordts, C Nora, C Yeang, JL Witztum European heart journal 41 (24), 2275-2284, 2020 | 455 | 2020 |
| Oxidized phospholipids, lipoprotein (a), and progression of calcific aortic valve stenosis R Capoulade, KL Chan, C Yeang, P Mathieu, Y Bossé, JG Dumesnil, ... Journal of the American College of Cardiology 66 (11), 1236-1246, 2015 | 439 | 2015 |
| PCSK9 association with lipoprotein (a) H Tavori, D Christian, J Minnier, D Plubell, MD Shapiro, C Yeang, ... Circulation research 119 (1), 29-35, 2016 | 204* | 2016 |
| ‘LDL-C’= LDL-C+ Lp (a)-C: implications of achieved ultra-low LDL-C levels in the proprotein convertase subtilisin/kexin type 9 era of potent LDL-C lowering C Yeang, JL Witztum, S Tsimikas Current opinion in lipidology 26 (3), 169-178, 2015 | 164 | 2015 |
| Atherogenic lipoprotein (a) increases vascular glycolysis, thereby facilitating inflammation and leukocyte extravasation JG Schnitzler, RM Hoogeveen, L Ali, KHM Prange, F Waissi, ... Circulation research 126 (10), 1346-1359, 2020 | 137 | 2020 |
| Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein (a) C Yeang, MY Hung, YS Byun, P Clopton, X Yang, JL Witztum, S Tsimikas Journal of clinical lipidology 10 (3), 594-603, 2016 | 132 | 2016 |
| Effect of pelacarsen on lipoprotein (a) cholesterol and corrected low-density lipoprotein cholesterol C Yeang, E Karwatowska-Prokopczuk, F Su, B Dinh, S Xia, JL Witztum, ... Journal of the American College of Cardiology 79 (11), 1035-1046, 2022 | 124 | 2022 |
| Association of mild to moderate aortic valve stenosis progression with higher lipoprotein (a) and oxidized phospholipid levels: secondary analysis of a randomized clinical trial R Capoulade, C Yeang, KL Chan, P Pibarot, S Tsimikas JAMA cardiology 3 (12), 1212-1217, 2018 | 106 | 2018 |
| Novel method for quantification of lipoprotein (a)-cholesterol: implications for improving accuracy of LDL-C measurements C Yeang, JL Witztum, S Tsimikas Journal of lipid research 62, 2021 | 98 | 2021 |
| Lipoprotein (a)-associated molecules are prominent components in plasma and valve leaflets in calcific aortic valve stenosis M Torzewski, A Ravandi, C Yeang, A Edel, R Bhindi, S Kath, ... Basic to Translational Science 2 (3), 229-240, 2017 | 89 | 2017 |
| Lipoprotein (a) and oxidized phospholipids in calcific aortic valve stenosis C Yeang, MJ Wilkinson, S Tsimikas Current opinion in cardiology 31 (4), 440-450, 2016 | 89 | 2016 |
| American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; and Council on Peripheral … G Reyes-Soffer, HN Ginsberg, L Berglund, PB Duell, SP Heffron, ... Arterioscler Thromb Vasc Biol 42 (1), e48-e60, 2022 | 83 | 2022 |
| Reduction of myocardial ischaemia–reperfusion injury by inactivating oxidized phospholipids C Yeang, D Hasanally, X Que, MY Hung, A Stamenkovic, D Chan, ... Cardiovascular research 115 (1), 179-189, 2019 | 82 | 2019 |
| Role of phospholipid transfer protein in high-density lipoprotein–mediated reverse cholesterol transport A Yazdanyar, C Yeang, XC Jiang Current atherosclerosis reports 13, 242-248, 2011 | 73 | 2011 |
| The domain responsible for sphingomyelin synthase (SMS) activity C Yeang, S Varshney, R Wang, Y Zhang, D Ye, XC Jiang Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2008 | 73 | 2008 |
| Relationship between “LDL-C”, estimated true LDL-C, apolipoprotein B-100, and PCSK9 levels following lipoprotein (a) lowering with an antisense oligonucleotide NJ Viney, C Yeang, X Yang, S Xia, JL Witztum, S Tsimikas Journal of clinical lipidology 12 (3), 702-710, 2018 | 65 | 2018 |
| Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis MB Boffa, TT Marar, C Yeang, NJ Viney, S Xia, JL Witztum, ... Journal of lipid research 60 (12), 2082-2089, 2019 | 61 | 2019 |
